Krane Funds Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $519K | Buy |
4,682
+498
| +12% | +$55.2K | 0.02% | 54 |
|
|
2025
Q1 | $469K | Sell |
4,184
-1,348
| -24% | -$151K | 0.01% | 56 |
|
|
2024
Q4 | $511K | Sell |
5,532
-575
| -9% | -$53.1K | 0.02% | 42 |
|
|
2024
Q3 | $512K | Buy |
6,107
+182
| +3% | +$15.3K | 0.02% | 50 |
|
|
2024
Q2 | $407K | Sell |
5,925
-114
| -2% | -$7.82K | 0.02% | 64 |
|
|
2024
Q1 | $436K | Buy |
6,039
+510
| +9% | +$36.9K | 0.02% | 76 |
|
|
2023
Q4 | $448K | Buy |
+5,529
| New | +$448K | 0.02% | 76 |
|
|
2023
Q3 | – | Sell |
-4,047
| Closed | -$312K | – | 110 |
|
|
2023
Q2 | $312K | Buy |
4,047
+107
| +3% | +$8.25K | 0.02% | 87 |
|
|
2023
Q1 | $325K | Sell |
3,940
-2,682
| -41% | -$221K | 0.01% | 81 |
|
|
2022
Q4 | $568K | Sell |
6,622
-835
| -11% | -$71.6K | 0.02% | 54 |
|
|
2022
Q3 | $460K | Sell |
7,457
-172
| -2% | -$10.6K | 0.02% | 75 |
|
|
2022
Q2 | $472K | Sell |
7,629
-1,020
| -12% | -$63.1K | 0.02% | 83 |
|
|
2022
Q1 | $514K | Buy |
8,649
+1,302
| +18% | +$77.4K | 0.02% | 145 |
|
|
2021
Q4 | $533K | Sell |
7,347
-386
| -5% | -$28K | 0.01% | 142 |
|
|
2021
Q3 | $540K | Sell |
7,733
-759
| -9% | -$53K | 0.01% | 143 |
|
|
2021
Q2 | $585K | Buy |
8,492
+2,125
| +33% | +$146K | 0.02% | 141 |
|
|
2021
Q1 | $411K | Buy |
6,367
+1,951
| +44% | +$126K | 0.02% | 249 |
|
|
2020
Q4 | $257K | Buy |
+4,416
| New | +$257K | 0.01% | 246 |
|